Microbiome analysis helps understand cause of chronic sinus condition, suggests cure

June 18, 2012

A study of the microbiome of the human nose provides clues to the cause of a chronic sinus condition and potential strategy for a cure. Researchers from the University of California, San Francisco report their findings today at the 2012 General Meeting of the American Society for Microbiology.

Chronic rhinosinusitis (CRS) is characterized by inflammation of the nasal and paranasal sinuses lasting over 12 weeks. Patients suffering from this disease experience a variety of symptoms including congestion, fatigue, and even depression and it can lead to other conditions such as asthma, meningitis and . Annually, it is estimated to be responsible for as many as 22 million office visits and more than 500,000 emergency department visits in the U.S. with reaching as high as $3.5 billion. The causes of are not completely understood. This has hampered development of long-lasting, definitive treatments.

"With the fast-growing body of literature that demonstrates associations between the human microbiome composition and several diseases such as asthma and obesity, we hypothesized that a nasal microbiome exists and plays a role in CRS development," says Nabeetha Nagalingam, a researcher on the study.

In the study Nagalingam and colleagues compared the nasal microbial communities of 10 CRS patients and 10 healthy individuals. They found that patients with CRS had a depleted nasal microbiome, characterized by a significant reduction in and an overgrowth of one type of bacteria, Corynebacterium spp.

"We investigated our hypothesis that C. tuberculostearicum in the setting of a depleted microbiome can induce pathophysiology consistent with sinusitis using a ," says Nagalingam.

To recreate a depleted microbiome, mice were administered antibiotics for 7 days before they were infected with C. tuberculostearicum. Mice who were given the antibiotic before exposure displayed symptoms of sinusitis. Mice that were not first treated with antibiotics but exposed to the bacteria did not.

"From our human microbiome comparative profiling, we noted that lactic acid bacteria, including Lactobacillus sakei, were significantly depleted in patients with CRS and postulated that this bacterium may have a protective role against CRS development," says Nagalingam. Once again using the mouse model they showed that L. sakei inhibited the growth of C. tuberculostearicum and could prevent infection, even with a depleted nasal microbiome.

"These findings suggest that manipulation of to restore colonization by beneficial species identified in this study may represent a novel and efficacious approach for prevention or management of CRS," says Nagalingam.

Explore further: IL-32 expression upregulated in chronic rhinosinusitis

More information: This research was presented as part of the 2012 General Meeting of the American Society for Microbiology held June 16-19, 2012 in San Francisco, California.

Related Stories

IL-32 expression upregulated in chronic rhinosinusitis

April 17, 2012
(HealthDay) -- Interleukin-32 (IL-32) mRNA expression is significantly higher in biopsies obtained from patients with chronic rhinosinusitis (CRS), compared to levels found in biopsies obtained from individuals without the ...

Recommended for you

New cellular approach found to control progression of chronic kidney disease

December 15, 2017
Researchers have demonstrated for the first time that extracellular vesicles - tiny protein-filled structures - isolated from amniotic fluid stem cells (AFSCs) can be used to effectively slow the progression of kidney damage ...

Testing shows differences in efficacy of Zika vaccines after one year

December 15, 2017
(Medical Xpress)—A large team of researchers with members from Harvard Medical School, Walter Reed Army Institute of Research, Bioqual Inc. and MIT has found that the efficacy of the three types of Zika vaccines currently ...

How to regulate fecal microbiota transplants

December 15, 2017
(Medical Xpress)—A small team of researchers at the University of Maryland, some with affiliations to the Veterans Affairs Maryland Health Care System, has written and published a Policy Forum piece in the journal Science ...

Urine test developed to test for tuberculosis

December 14, 2017
(Medical Xpress)—An international team of researchers has developed a urine test that can be used to detect tuberculosis (TB) in human patients. In their paper published in Science Translational Medicine, the group describes ...

40 years after first Ebola outbreak, survivors show signs they can stave off new infection

December 14, 2017
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study ...

Aging impairs innate immune response to flu

December 13, 2017
Aging impairs the immune system's response to the flu virus in multiple ways, weakening resistance in older adults, according to a Yale study. The research reveals why older people are at increased risk of illness and death ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.